MigVax Ltd.

Grantee website Kiryat Shemona, Israel

Purpose

to support early evaluation of a novel technology that could be used with polio VLP-based vaccines to induce mucosal immunity, providing a non-infectious polio vaccine that would protect against transmission in the countries at highest risk

Division

Global Development

Date

SEPTEMBER 2024

Region served

GLOBAL

Committed amount

$600,418

Grant topic

Polio

Duration (months)

21

Grantee location

Kiryat Shemona, Israel

Related work

More about our financials

Our story

Learn about the origins of the foundation and the values that drive our work.

Our work

Learn about where we work around the globe and the programs we’ve created to address urgent issues in global health, global development, and education.

How we work

We are focused on results. Those that can be measured. And those measured in ways beyond numbers.